Arcutis Biotherapeutics, Inc. Common Stock ARQT
$26.22
-2.02%
at last close
Financials (TTM)
- Revenue
- $415.62 million
- Net Income
- $-2,376,000
- Net Margin
- -0.57%
- Return on Equity
- -1.25%
- Debt-to-Equity
- 0.58
- P/E Ratio
- —
- Price / Book
- 17.29
- Price / Sales
- 7.89
Over the trailing twelve months, Arcutis Biotherapeutics, Inc. Common Stock generated revenue of $415.62 million and net income of $-2,376,000, a net margin of -0.57%.
At the last closing price of $26.22, ARQT trades at 7.89 times sales, with a market capitalization of $3.28 billion.
Key Stats
- Last Close
- $26.22
- Market Cap
- $3.28 billion
- 52-Week Range
- $12.72 – $31.77
- Average Volume
- 1.91 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.